JDRF T1D Fund
Overview
The JDRF T1D Fund is a mission-driven venture philanthropy platform focused on investment in early-stage T1D commercial opportunities.\
Investment Focus
- Companies developing therapies to treat, prevent, and cure Type 1 Diabetes
Portfolio Companies
Reach JDRF T1D Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about JDRF T1D Fund
What sectors does JDRF T1D Fund invest in?
JDRF T1D Fund invests in Healthcare, Life Sciences, Medical Devices, Diagnostics, Vaccines and Biopharmaceutical, and is based in Boston, Massachusetts, United States. JDRF T1D Fund is listed as a venture capital in the ConnectSafely investor database.
What stage does JDRF T1D Fund invest at?
JDRF T1D Fund backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 1M - 50M.
Which regions does JDRF T1D Fund invest in?
JDRF T1D Fund invests across United States.
Who are the partners at JDRF T1D Fund?
Team members listed for JDRF T1D Fund include Elizabeth Mily (Chief Executive Officer) and Eric Shen (Chief of Staff).
What companies has JDRF T1D Fund invested in?
JDRF T1D Fund's portfolio includes Semma Therapeutics, Immunocore, Provention Bio, Pandion Therapeutics, Inversago Pharma and Protomer Technologies.
How do I contact JDRF T1D Fund?
JDRF T1D Fund's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
